Pain Org Issues Statement on Rescheduling Marijuana
The American Society of Regional Anesthesia and Pain Medicine (ASRA) issued a formal statement calling for the rescheduling of marijuana and called for more research to determine its safety and effectiveness this week.
The organization notes that there is a lack of evidence regarding the long-term effects of marijuana use, and overlapping state and federal laws create huge obstacles for physicians who may want to prescribe it. Under the current federal law, clinical research on marijuana is hindered, and physicians are faced with difficult ethical and legal questions.
“Many patients could potentially benefit from its use,” said ASRA Board member Samer Narouze, MD, PhD. “Neuropathic pain is probably the indication with the most convincing clinical evidence,” he said.
“Other indications with promising results include anxiety, depression, seizures, cancer pain, and HIV-related pain. However, because medical marijuana lacks the FDA quality and safety oversight, there is inconsistency in doses, which can...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin